#news #biotech Iterum bags $65M for phase 3 trial of ex-Pfizer antibiotic

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Iterum bags $65M for phase 3 trial of ex-Pfizer antibiotic .Iterum has completed a $65 million (€58 million) Series B to equip it to take its antibiotic sulopenem through phase 3. The financing moves the total raised by the Irish biopharma company since it emerged last year armed with an antibiotic developed by Pfizer past the $100 million mark.

from FierceBiotech: Biotech http://ift.tt/2ryn2A8